Bruker Corp. Appoints Bonnie H. Anderson to Board of Directors

Bruker Corp. has appointed Bonnie H. Anderson to its board of directors. Anderson is co-founder, chairman of the board, and CEO of Veracyte, a global genomic diagnostics company. Anderson spent 18 years at Beckman Coulter in leadership positions across the global life sciences and diagnostic business segments, including flow cytometry, before co-founding Veracyte. The company now qualifies as public global, with a market capitalization of nearly $2 billion.

"The addition of Bonnie to our board is very timely as we continue to evolve our Project Accelerate initiatives in multiomics life science and clinical research tools toward molecular diagnostics solutions,” said Frank Laukien, Bruker’s chairman, president, and CEO.

The appointment was effective as of Sept. 3.